Life ScienceCompany
Biohaven Pharmaceutical Holding M&A Summary
Biohaven Pharmaceutical Holding has acquired 1 company of its own, including 1 in the last 5 years.
Biohaven Pharmaceutical Holding’s largest acquisition to date was in 2022, when it acquired Channel Biosciences for $100M. Biohaven Pharmaceutical Holding has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Biohaven Pharmaceutical Holding Ownership
Who owns Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding is owned by Pfizer. It was acquired on May 10, 2022.
Biohaven Pharmaceutical Holding Business Overview
Where is Biohaven Pharmaceutical Holding headquartered?
Biohaven Pharmaceutical Holding is headquartered in New Haven, Connecticut.
What is Biohaven Pharmaceutical Holding’s revenue?
Biohaven Pharmaceutical Holding disclosed revenue of 463M USD for 2021 and 64M USD for 2020.
How many employees does Biohaven Pharmaceutical Holding have?
Biohaven Pharmaceutical Holding has 928 employees.
What sector is Biohaven Pharmaceutical Holding in?
Biohaven Pharmaceutical Holding is a life science company.
When was Biohaven Pharmaceutical Holding founded?
Biohaven Pharmaceutical Holding was founded in 2013.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1